Volume 67 Received 10 May 2011 | ||||||||||
| ||||||||||
aSchool of Industrial Technology, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, and bX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia
Correspondence e-mail: hkfun@usm.my
In the title compound, C8H7N3O2·H2O, the 2-methyl-5-nitro-1H-benzimidazole molecule, excluding the methyl H atoms, is approximately planar, with a maximum deviation of 0.137 (1) Å. The crystal structure is stabilized by water molecules via N-H
O(water), O(water)-H
O and O(water)-H
N hydrogen bonds, forming sheets parallel to the (100) plane. A short intermolecular contact between the benzene and imidazole rings, with a centroid-centroid distance of 3.6419 (10) Å, indicates a
-
interaction.
For general background to and the potential biological activity of benzimidazole derivatives, see: Puratchikody et al. (2008
); Tonelli et al. (2010
); Shingalapur et al. (2010
); Refaat (2010
); Lazer et al. (1987
). For the preparation of the title compound, see: Umare et al. (2008
); Singh & Pathak (2008
). For the stability of the temperature controller used in the data collection, see: Cosier & Glazer (1986
). For standard bond-length data, see: Allen et al. (1987
). For related structures, see: Eltayeb et al. (2009
); Arumugam et al. (2010
).
|
|
|
Data collection: APEX2 (Bruker, 2009
); cell refinement: SAINT (Bruker, 2009
); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008
); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: IS2711 ).
We would like to acknowledge Universiti Sains Malaysia (USM) for the University Grant 1001/PTEKIND/8140152. HKF and CKQ also thank USM for the Research University Grant (No. 1001/PFIZIK/811160).
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Arumugam, N., Abdul Rahim, A. S., Osman, H., Quah, C. K. & Fun, H.-K. (2010). Acta Cryst. E66, o2412-o2413.
![[details]](../../../../../../e/graphics/details.gif)
Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105-107.
![[details]](../../../../../../j/graphics/details.gif)
Eltayeb, N. E., Teoh, S. G., Quah, C. K., Fun, H.-K. & Adnan, R. (2009). Acta Cryst. E65, o1613-o1614.
![[details]](../../../../../../e/graphics/details.gif)
Lazer, E. S., Matteo, M. R. & Possanza, G. J. (1987). J. Med. Chem. 30, 726-729.
![[ISI]](../../../../../../logos/isiborder.gif)
Puratchikody, A., Nagalakshmi, G. & Doble, M. (2008). Chem. Pharm. Bull. 56, 273-281.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Refaat, H. M. (2010). Eur. J. Med. Chem. 45, 2949-2956.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Shingalapur, R. V., Hosamani, K. M., Keri, R. S. & Hugar, M. H. (2010). Eur. J. Med. Chem. 45, 1753-1759.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Singh, J. & Pathak, D. P. (2008). Orient. J. Chem. 24, 175-180. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Tonelli, M., Simone, M., Tasso, B., Novelli, F., Boido, V., Sparatore, F., Paglietti, G., Pricl, S., Giliberti, G., Blois, S., Ibba, C., Sanna, G., Loddo, R. & La Colla, P. (2010). Bioorg. Med. Chem. 18, 2937-2953.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Umare, V. D., Ingle, V. N. & Wanare, R. K. (2008). Indian J. Heterocycl. Chem. 17, 253-256. ![[ChemPort]](../../../../../../logos/chemportborder.gif)